Article Text
Statistics from Altmetric.com
Commentary on: OpenUrlAbstract/FREE Full Text
Context
Oral anticoagulants (OACs) substantially reduce stroke risk in patients with atrial fibrillation (AF); however, they remain globally underused.1 One of the main reasons is the difficulty in stratifying AF-related ischaemic stroke risk at the individual patient level.1 ,2 Among scores stratifying AF-related stroke risk, CHA2-DS2-Vasc prevails in most recent international AF guidelines.3 ,4 Still, it remains unknown whether AF-related stroke risk is stable across regions, international cohorts or within specific CHA2-DS2-Vasc score strata.
Methods
This systematic review included only studies reporting ischaemic stroke rates for patients with AF not on OACs, and assessed …
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.